分享至
15:36 【通化东宝：可溶性甘精赖脯双胰岛素注射液临床获批】财联社3月10日电，通化东宝公告，可溶性甘精赖脯双胰岛素注射液（THDB0207）申报临床获得批准。
特别声明：以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布，本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.
